Under the agreement, Thermo's manufacturing site in North Carolina will be used for aseptic fill and finish, labeling, and packaging to support the production of hundreds of millions of doses of Moderna's vaccine. Production will start in the third quarter of 2021.

Moderna vaccine 100% effective for teens
Moderna announced its phase II/III study of its COVID-19 vaccine in adolescents has met its primary immunogenicity endpoint with no cases of COVID-19...

Moderna inks South Korean mRNA vaccine collaborations
Moderna has inked two memoranda of understanding agreements with South Korea for messenger RNA (mRNA) vaccine research and manufacturing in that country.

Thermo Fisher to open cell center, debut microscope
Thermo Fisher Scientific has announced it will open a cell therapy center with the University of California, San Francisco. The company has also unveiled...

Thermo Fisher announces Q1 revenue increase
Thermo Fisher Scientific said that its efforts to help scale vaccine production and support diagnostic testing globally during the COVID-19 pandemic were...

Thermo Fisher to sell Progen primary antibodies
Gene therapy tools manufacturer Progen Biotechnik has signed a nonexclusive distribution agreement with Thermo Fisher Scientific.